Tumors establish resistance to immunotherapy by regulating T<sub>reg</sub>recruitment via CCR4Lisa A. Marshall(Rapt Therapeutics (United States)), Oezcan Talay(Rapt Therapeutics (United States))Journal for ImmunoTherapy of CancerNovember 1, 202010.1136/jitc-2020-000764Cited by 141SaveCiteExport RISWatch citationsRelated PapersPotent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy|Journal of Medicinal Chemistry|2022|12